Shanghai Pharmaceutical Co Ltd (601607) - Financial and Strategic SWOT Analysis Review

Shanghai Pharmaceutical Co Ltd (601607) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by it to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler and distributor of healthcare products. The company carries out the research and development, manufacture and sale of pharmaceutical products for treating HER2 positive advanced breast cancer, systemic anti-infection, and antineoplastic drug and immunomodulator. It also offers pharmaceuticals for diseases and disorders of cardiovascular system, digestive and metabolism, neurological system, musculoskeletal system, and respiratory system. The company also provides distribution and supply chain solutions to pharmaceutical manufacturers and dispensers; operates retail pharmacy stores; and provides consulting services, assets management and other services. Shanghai Pharma also provides traditional Chinese medicines. The company operates through a group of subsidiaries in China. Shanghai Pharma is headquartered in Shanghai, China.

Shanghai Pharmaceutical Co Ltd Key Recent Developments

May 02,2018: Shanghai Pharmaceuticals Registered Growth of Over 30%
Apr 26,2018: Shanghai Pharma Listed on Brand Finance China 300 Ranking 2nd in the Pharmaceutical Industry
Apr 06,2018: Shanghai Pharma Investment Cooperation Forum was held at HKSTPC to discuss innovation cooperation
Mar 23,2018: Shanghai Pharmaceuticals: Growth in Pharmaceutical Business Picked Up in 2017 with Improvement in Quality and Efficiency of Business Development
Jan 18,2018: CBMG Accelerates Cell Therapy Manufacturing with GE Healthcares New Start-to-Finish Solution

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Shanghai Pharmaceutical Co Ltd - Key Facts 6
Shanghai Pharmaceutical Co Ltd - Key Employees 7
Shanghai Pharmaceutical Co Ltd - Key Employee Biographies 8
Shanghai Pharmaceutical Co Ltd - Major Products and Services 9
Shanghai Pharmaceutical Co Ltd - History 10
Shanghai Pharmaceutical Co Ltd - Company Statement 13
Shanghai Pharmaceutical Co Ltd - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Affiliate 18
Section 2 Company Analysis 20
Company Overview 20
Shanghai Pharmaceutical Co Ltd - Business Description 21
Business Segment: Distribution and Supply Chain Solutions 21
Overview 21
Overview 21
Key Stats 21
Business Segment: Other Business Operations 21
Overview 21
Performance 21
Business Segment: Pharmaceutical Business 21
Overview 21
Performance 22
Business Segment: Pharmaceutical Retail 22
Overview 22
Performance 22
Key Stats 22
R&D Overview 22
Shanghai Pharmaceutical Co Ltd - Corporate Strategy 23
Shanghai Pharmaceutical Co Ltd - SWOT Analysis 24
SWOT Analysis - Overview 24
Shanghai Pharmaceutical Co Ltd - Strengths 24
Shanghai Pharmaceutical Co Ltd - Weaknesses 25
Shanghai Pharmaceutical Co Ltd - Opportunities 26
Shanghai Pharmaceutical Co Ltd - Threats 27
Shanghai Pharmaceutical Co Ltd - Key Competitors 28
Section 3 Company Financial Ratios 29
Financial Ratios - Capital Market Ratios 29
Financial Ratios - Annual Ratios 30
Performance Chart 33
Financial Performance 33
Financial Ratios - Interim Ratios 34
Financial Ratios - Ratio Charts 35
Section 4 Companys Lifesciences Financial Deals and Alliances 36
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 36
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 37
Shanghai Pharmaceutical Co Ltd, Recent Deals Summary 38
Section 5 Companys Recent Developments 39
May 02, 2018: Shanghai Pharmaceuticals Registered Growth of Over 30% 39
Apr 26, 2018: Shanghai Pharma Listed on Brand Finance China 300 Ranking 2nd in the Pharmaceutical Industry 41
Apr 06, 2018: Shanghai Pharma Investment Cooperation Forum was held at HKSTPC to discuss innovation cooperation 42
Mar 23, 2018: Shanghai Pharmaceuticals: Growth in Pharmaceutical Business Picked Up in 2017 with Improvement in Quality and Efficiency of Business Development 43
Jan 18, 2018: CBMG Accelerates Cell Therapy Manufacturing with GE Healthcares New Start-to-Finish Solution 45
Dec 28, 2017: Shanghai Pharma convened technology innovation meeting and announced SPH Best R&D Case 2017 46
Dec 22, 2017: SHTCM contracted with Longde 47
Oct 30, 2017: Shanghai Pharmaceuticals Realized Stable Results In the Third Quarter Industrial Income Sustained High and Stable Growth Research and Development Capabilities Reaffirmed 48
Oct 30, 2017: Shanghai Pharmaceuticals Realized Stable Results In the Third Quarter 49
Sep 22, 2017: Shanghai Pharma Tops the Asian Pharmaceutical Industry in Brand Value 50
Section 6 Appendix 51
Methodology 51
Ratio Definitions 51
About GlobalData 55
Contact Us 55
Disclaimer 55

List Of Tables


Shanghai Pharmaceutical Co Ltd, Key Facts 6
Shanghai Pharmaceutical Co Ltd, Key Employees 7
Shanghai Pharmaceutical Co Ltd, Key Employee Biographies 8
Shanghai Pharmaceutical Co Ltd, Major Products and Services 9
Shanghai Pharmaceutical Co Ltd, History 10
Shanghai Pharmaceutical Co Ltd, Subsidiaries 17
Shanghai Pharmaceutical Co Ltd, Affiliate 18
Shanghai Pharmaceutical Co Ltd, Key Competitors 28
Shanghai Pharmaceutical Co Ltd, Ratios based on current share price 29
Shanghai Pharmaceutical Co Ltd, Annual Ratios 30
Shanghai Pharmaceutical Co Ltd, Annual Ratios (Cont...1) 31
Shanghai Pharmaceutical Co Ltd, Annual Ratios (Cont...2) 32
Shanghai Pharmaceutical Co Ltd, Interim Ratios 34
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 36
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 37
Shanghai Pharmaceutical Co Ltd, Recent Deals Summary 38
Currency Codes 51
Capital Market Ratios 51
Equity Ratios 52
Profitability Ratios 52
Cost Ratios 53
Liquidity Ratios 53
Leverage Ratios 54
Efficiency Ratios 54

List Of Figures


Shanghai Pharmaceutical Co Ltd, Performance Chart (2013 - 2017) 33
Shanghai Pharmaceutical Co Ltd, Ratio Charts 35
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 36
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 37

Shanghai Electric Power Co Ltd (600021) - Financial and Strategic SWOT Analysis Review

Shanghai Electric Power Co., Ltd. (Shanghai Electric Power), a subsidiary of State Power Investment Corporation is an electric energy company that generates and supplies electricity and thermal power. The company

USD 300 View Report

Sinopec Shanghai Petrochemical Co Ltd (600688) - Financial and Strategic SWOT Analysis Review

Sinopec Shanghai Petrochemical Co Ltd (600688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been

USD 125 View Report

2018 Pharmaceutical Competitive Intelligence: Zoetis Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization and

USD 950 View Report

2018 Pharmaceutical Competitive Intelligence: Valeant Pharmaceuticals Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization and

USD 950 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available